Administrative Controls/FAST
-
- Scope: 24 Priority countries + Global?
- Focus: NTP, NGOs, civil society?
- Objectives:
- Describe the FAST approach to infection control
- Describe FAST in the context of updated WHO guidelines
- Describe measurement, monitoring and evaluation of FAST
- Expected Outputs/Outcomes: After attending the webinar, participants will be able to
- Describe the concepts behind FAST
- Which of the following is NOT a FAST concept:
- Screening upon entry
- Immediate contact tracing
- Prompt testing with molecular diagnostics
- Describe measurement, monitoring and evaluation aspects of FAST
- Which is an example process indicator for measuring FAST
- Proportion of patients screened for active TB disease upon hospital entry
- Proportion of presumptive patients given a mask
- Proportion of all confirmed TB contacts tested
- Understand how FAST concepts fit into the updated WHO guidelines
- Are FAST principles included in the updated WHO IPC guidelines?
- Yes
- Detailed Outline:
- Introduction/Purpose:
- Describe the FAST approach at a high level
- Country examples
- Describe FAST in the context of new WHO guidelines and as a way to implement administrative controls
- Describe the measurement, monitoring and evaluation of FAST
- Describe the FAST approach at a high level
- An overview of FAST
- Finding cases Actively
- Deliver a symptom screen for each person entering a facility
- Separating Safely
- For those screening presumptive for TB, move to a separate waiting area
- Treating Effectively
- For those who are presumptive, collect sputum for a molecular test (usually GeneXpert)
- Deliver results quickly (<2 days) and begin appropriate therapy (taking into account the patient’s drug resistance profile)
- FAST as an administrative control approach
- Can work to identify TB patients who would be missed by the health system otherwise
- e., in HIV wards, antenatal care wards, staff clinics etc (i.e., not TB wards)
- Can deliver more effective therapy through universal drug resistance profiling
- Can initiate people on treatment more quickly through rapid molecular tests like GXP
- Can work to identify TB patients who would be missed by the health system otherwise
- Measuring, monitoring and evaluating FAST
- Facility level
- % of hospitalized patients screened for active TB
- % of presumptive patients tested for TB with GXP
- % of presumptive patients tested for TB with GXP within one day of admission
- Ideally collect admission and test date to derive actual number of days
- % of those testing positive for TB who initiate appropriate therapy
- National level
- % of facilities with:
- > 90% patients screened for active TB
- >90% presumptive patients tested for active TB with Xpert
- >90% of presumptive patients tested for active TB with Xpert within 1 day of admission
- >90% confirmed patients started on appropriate therapy
- Could add something about cost per patient identified
- % of facilities with:
- Country example: Implementing FAST in South Africa
- Initial rollout
- Describe ward level screening
- Scale up
- Measurement
- Focus on data analytics and on TAT calculation
- Plans for future expansion
- Initial rollout
- Questions
- Conclusions
- Facility level
- Finding cases Actively
- Introduction/Purpose:
- Are FAST principles included in the updated WHO IPC guidelines?
- Which is an example process indicator for measuring FAST
- Which of the following is NOT a FAST concept:
- Describe the concepts behind FAST
- Click here to join the webinar on July 22, 2019 Time at 9 AM EST